Skip to main content

Table 2 Surgery, pathological response, and adjuvant systemic treatment

From: Feasibility of radioguided occult lesion localization of clip-marked lymph nodes for tailored axillary treatment in breast cancer patients treated with neoadjuvant systemic therapy

  n (%)
No. of procedures 38
Breast surgery
 Mastectomy 13 (34.2)
 Breast-conserving surgery 25 (65.8)
ypT-stage
 pCR 7 (18.4)
 1 19 (50.0)
 2 11 (28.9)
 3 1 (2.6)
yiN-stage
yiN0 12 (31.6)
yiN+ 26 (68.4)
ypN-stage
 0 10 (26.3)
 1 18 (47.4)
 2 5 (13.2)
 3 4 (10.5)
 Unknowna 1 (2.6)
Outcome ROLL-marked node
 pCR 10 (26.3)
  Marker in nodeb 8
  No marker present 2
 Residual disease 27 (71.1)
  Macro-metastasis 24
  Micro-metastasis 2
  Isolated tumor cells 1
 Unknowna 1 (2.6)
Adjuvant systemic therapy
 HT 24 (63.2)
 HT + TT 4 (10.5)
 HT + CT 1 (2.6)
 TT 2 (5.3)
 No adjuvant systemic therapy 7 (18.4)
  1. aNo lymph node was found during the ROLL-node procedure in one patient
  2. bIn one patient, the ROLL-marked node was initially not found, but removed during a second ROLL-node procedure
  3. HT hormone therapy, TT targeted therapy, CT chemotherapy